Baidu
map

感染指南

订阅

MedSci主页 / 所有栏目 / 感染指南

2017 KSID临床指南：社区获得性皮肤和软组织感染的抗生素治疗

2017-12-04 韩国感染病学会 Infect Chemother. 2017 Dec;49(4):301-325.

社区获得性皮肤和软组织感染抗生素治疗

皮肤和软组织感染是常见的重要的感染性疾病，本文是对2012年韩国皮肤和软组织感染指南的更新，文章主要对皮肤和软组织感染的诊断和管理提出指导建议，包括脓包疮/脓疮，化脓性皮肤软组织感染，丹毒和蜂窝织炎，坏死性筋膜炎，化脓性肌炎，气性坏疽以及咬伤。该指南主要面向大于等于16岁人群社区获得性皮肤和软组织感染患者。

中文标题：

2017 KSID临床指南：社区获得性皮肤和软组织感染的抗生素治疗

英文标题：

Clinical Guidelines for the Antibiotic Treatment for Community-Acquired Skin and Soft Tissue Infection.

发布机构：

韩国感染病学会

发布日期：

2017-12-04

简要介绍：

皮肤和软组织感染是常见的重要的感染性疾病，本文是对2012年韩国皮肤和软组织感染指南的更新，文章主要对皮肤和软组织感染的诊断和管理提出指导建议，包括脓包疮/脓疮，化脓性皮肤软组织感染，丹毒和蜂窝织炎，坏死性筋膜炎，化脓性肌炎，气性坏疽以及咬伤。该指南主要面向大于等于16岁人群社区获得性皮肤和软组织感染患者。

 

拓展指南：与感染相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2017 KSID临床指南：社区获得性皮肤和软组织感染的抗生素治疗)] GetToolGuiderByIdResponse(projectId=1, id=254771c0015a18f8, title=2017 KSID临床指南：社区获得性皮肤和软组织感染的抗生素治疗, enTitle=Clinical Guidelines for the Antibiotic Treatment for Community-Acquired Skin and Soft Tissue Infection., guiderFrom=Infect Chemother. 2017 Dec;49(4):301-325., authorId=null, author=, summary=皮肤和软组织感染是常见的重要的感染性疾病，本文是对2012年韩国皮肤和软组织感染指南的更新，文章主要对皮肤和软组织感染的诊断和管理提出指导建议，包括脓包疮/脓疮，化脓性皮肤软组织感染，丹毒和蜂窝织炎，坏死性筋膜炎，化脓性肌炎，气性坏疽以及咬伤。该指南主要面向大于等于16岁人群社区获得性皮肤和软组织感染患者。 , cover=, journalId=null, articlesId=null, associationId=1578, associationName=韩国感染病学会, associationIntro=, copyright=0, guiderPublishedTime=Mon Dec 04 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>皮肤和软组织感染是常见的重要的感染性疾病，本文是对2012年韩国皮肤和软组织感染指南的更新，文章主要对皮肤和软组织感染的诊断和管理提出指导建议，包括脓包疮/脓疮，化脓性皮肤软组织感染，丹毒和蜂窝织炎，坏死性筋膜炎，化脓性肌炎，气性坏疽以及咬伤。该指南主要面向大于等于16岁人群社区获得性皮肤和软组织感染患者。 </P> <P> </P>拓展指南：<STRONG>与<FONT color=red>感染</FONT>相关指南：</STRONG><BR> <UL> <LI><A title="2017 ESPGHAN意见书：儿童慢性丙肝感染的治疗" target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=f36541c0015a0175">2017 ESPGHAN意见书：儿童慢性丙肝感染的治疗</A> <LI><A title=HPV感染疾病相关问题专家共识（2017） target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=9df0c1c00153e174">HPV感染疾病相关问题专家共识（2017）</A> <LI><A title=泌尿道感染诊治循证指南（2016） target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=263b91c00153ae65">泌尿道感染诊治循证指南（2016）</A> <LI><A title=NCCN临床实践指南：癌症相关感染的预防和治疗（2018.V1） target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=a87a61c0015305d1">NCCN临床实践指南：癌症相关感染的预防和治疗（2018.V1）</A> <LI><A title=感染性疾病相关个体化医学分子检测技术指南 target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=ce1ae1c00152958c">感染性疾病相关个体化医学分子检测技术指南</A> 更多信息请点击：<A target=_blank href="//m.capotfarm.com/guideline/list.do?q=%E6%84%9F%E6%9F%93">有关感染更多指南</A></LI></UL>, tagList=[TagDto(tagId=68004, tagName=社区获得性皮肤和软组织感染), TagDto(tagId=4247, tagName=抗生素治疗)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8102, appHits=265, showAppHits=0, pcHits=5012, showPcHits=3831, likes=131, shares=11, comments=11, approvalStatus=1, publishedTime=Tue Jan 09 22:38:17 CST 2018, publishedTimeString=2017-12-04, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Jan 09 22:38:17 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 11:37:40 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 KSID临床指南：社区获得性皮肤和软组织感染的抗生素治疗)])
2017 KSID临床指南：社区获得性皮肤和软组织感染的抗生素治疗
下载请点击：
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1194339, encodeId=18bf1194339b3, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aad56507164, createdName=ms9000001162788533, createdTime=Thu Feb 17 09:24:44 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964091, encodeId=fae896409141, content=学习学习.了解了解, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/afbaf47f8410484296e20353a49380c3/71b4a3ef39464967b21183f90434c121.jpg, createdBy=a04b5145063, createdName=美尼尔, createdTime=Sun May 09 21:17:12 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277848, encodeId=2f382e7848a9, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Fri Jan 12 14:00:42 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277836, encodeId=e6eb2e783662, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Fri Jan 12 13:51:35 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277801, encodeId=0d952e780119, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Jan 12 10:02:39 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
    2022-02-17 ms9000001162788533

    学习一下

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1194339, encodeId=18bf1194339b3, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aad56507164, createdName=ms9000001162788533, createdTime=Thu Feb 17 09:24:44 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964091, encodeId=fae896409141, content=学习学习.了解了解, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/afbaf47f8410484296e20353a49380c3/71b4a3ef39464967b21183f90434c121.jpg, createdBy=a04b5145063, createdName=美尼尔, createdTime=Sun May 09 21:17:12 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277848, encodeId=2f382e7848a9, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Fri Jan 12 14:00:42 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277836, encodeId=e6eb2e783662, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Fri Jan 12 13:51:35 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277801, encodeId=0d952e780119, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Jan 12 10:02:39 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
    2021-05-09 美尼尔

    学习学习.了解了解

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1194339, encodeId=18bf1194339b3, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aad56507164, createdName=ms9000001162788533, createdTime=Thu Feb 17 09:24:44 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964091, encodeId=fae896409141, content=学习学习.了解了解, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/afbaf47f8410484296e20353a49380c3/71b4a3ef39464967b21183f90434c121.jpg, createdBy=a04b5145063, createdName=美尼尔, createdTime=Sun May 09 21:17:12 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277848, encodeId=2f382e7848a9, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Fri Jan 12 14:00:42 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277836, encodeId=e6eb2e783662, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Fri Jan 12 13:51:35 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277801, encodeId=0d952e780119, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Jan 12 10:02:39 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
    2018-01-12 1e0e5a1fm42(暂无匿称)

    henhao

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1194339, encodeId=18bf1194339b3, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aad56507164, createdName=ms9000001162788533, createdTime=Thu Feb 17 09:24:44 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964091, encodeId=fae896409141, content=学习学习.了解了解, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/afbaf47f8410484296e20353a49380c3/71b4a3ef39464967b21183f90434c121.jpg, createdBy=a04b5145063, createdName=美尼尔, createdTime=Sun May 09 21:17:12 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277848, encodeId=2f382e7848a9, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Fri Jan 12 14:00:42 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277836, encodeId=e6eb2e783662, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Fri Jan 12 13:51:35 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277801, encodeId=0d952e780119, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Jan 12 10:02:39 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
    2018-01-12 137****9095

    henhao

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1194339, encodeId=18bf1194339b3, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aad56507164, createdName=ms9000001162788533, createdTime=Thu Feb 17 09:24:44 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964091, encodeId=fae896409141, content=学习学习.了解了解, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/afbaf47f8410484296e20353a49380c3/71b4a3ef39464967b21183f90434c121.jpg, createdBy=a04b5145063, createdName=美尼尔, createdTime=Sun May 09 21:17:12 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277848, encodeId=2f382e7848a9, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Fri Jan 12 14:00:42 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277836, encodeId=e6eb2e783662, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Fri Jan 12 13:51:35 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277801, encodeId=0d952e780119, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Jan 12 10:02:39 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
    2018-01-12 大爰

    学习了谢谢分享!!

    0

以上为热门评论，梅斯医学App还有更多内容
Baidu
map
Baidu
map
Baidu
map